SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-11-012457
Filing Date
2011-03-04
Accepted
2011-03-04 16:30:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 a11-7271_1424b5.htm 424B5 749989
2 GRAPHIC g72711eai001.jpg GRAPHIC 4395
3 GRAPHIC g72711bei001.jpg GRAPHIC 4395
4 GRAPHIC g72711eci001.jpg GRAPHIC 4395
5 GRAPHIC g72711eei001.jpg GRAPHIC 4393
6 GRAPHIC g72711dsi001.jpg GRAPHIC 4395
  Complete submission text file 0001104659-11-012457.txt   782077
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-159606 | Film No.: 11665040
SIC: 2836 Biological Products, (No Diagnostic Substances)